These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23999222)

  • 21. Beta-casein and its complexes with chitosan as nanovehicles for delivery of a platinum anticancer drug.
    Razmi M; Divsalar A; Saboury AA; Izadi Z; Haertlé T; Mansuri-Torshizi H
    Colloids Surf B Biointerfaces; 2013 Dec; 112():362-7. PubMed ID: 24028849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contractility as a prerequisite for TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts.
    Meyer-ter-Vehn T; Sieprath S; Katzenberger B; Gebhardt S; Grehn F; Schlunck G
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4895-904. PubMed ID: 17065504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles.
    Cadete A; Figueiredo L; Lopes R; Calado CC; Almeida AJ; Gonçalves LM
    Eur J Pharm Sci; 2012 Mar; 45(4):451-8. PubMed ID: 21986445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preparation and characterization of biotinylated chitosan nanoparticles].
    Yao Q; Hou SX; Zhang X; Zhao G; Gou XJ; You JZ
    Yao Xue Xue Bao; 2007 May; 42(5):557-61. PubMed ID: 17703783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative effects of TGF-beta 1 and TGF-beta 2 on extracellular matrix production, proliferation, migration, and collagen contraction of human Tenon's capsule fibroblasts in pseudoexfoliation and primary open-angle glaucoma.
    Kottler UB; Jünemann AG; Aigner T; Zenkel M; Rummelt C; Schlötzer-Schrehardt U
    Exp Eye Res; 2005 Jan; 80(1):121-34. PubMed ID: 15652533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanoparticle formation by using shellac and chitosan for a protein delivery system.
    Kraisit P; Limmatvapirat S; Nunthanid J; Sriamornsak P; Luangtana-anan M
    Pharm Dev Technol; 2013; 18(3):686-93. PubMed ID: 22568768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and evaluation of warfarin-β-cyclodextrin loaded chitosan nanoparticles for transdermal delivery.
    Khalil SK; El-Feky GS; El-Banna ST; Khalil WA
    Carbohydr Polym; 2012 Oct; 90(3):1244-53. PubMed ID: 22939337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.
    Oyarzun-Ampuero FA; Brea J; Loza MI; Torres D; Alonso MJ
    Int J Pharm; 2009 Nov; 381(2):122-9. PubMed ID: 19467809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silibinin inhibits myofibroblast transdifferentiation in human tenon fibroblasts and reduces fibrosis in a rabbit trabeculectomy model.
    Chen YH; Liang CM; Chen CL; Chen JT; Chang YH; Lu DW; Chien KH; Tai MC
    Acta Ophthalmol; 2013 Nov; 91(7):e506-15. PubMed ID: 23764119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted siRNA delivery by anti-HER2 antibody-modified nanoparticles of mPEG-chitosan diblock copolymer.
    Wang Y; Liu P; Du J; Sun Y; Li F; Duan Y
    J Biomater Sci Polym Ed; 2013; 24(10):1219-32. PubMed ID: 23713424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors.
    Bilensoy E; Sarisozen C; Esendağli G; Doğan AL; Aktaş Y; Sen M; Mungan NA
    Int J Pharm; 2009 Apr; 371(1-2):170-6. PubMed ID: 19135514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic heparin delivery by the pulmonary route using chitosan and glycol chitosan nanoparticles.
    Trapani A; Di Gioia S; Ditaranto N; Cioffi N; Goycoolea FM; Carbone A; Garcia-Fuentes M; Conese M; Alonso MJ
    Int J Pharm; 2013 Apr; 447(1-2):115-23. PubMed ID: 23454518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel PEGylation of chitosan nanoparticles for gene delivery.
    Zhang Y; Chen J; Zhang Y; Pan Y; Zhao J; Ren L; Liao M; Hu Z; Kong L; Wang J
    Biotechnol Appl Biochem; 2007 Apr; 46(Pt 4):197-204. PubMed ID: 17147512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced immune response against pertussis toxoid by IgA-loaded chitosan-dextran sulfate nanoparticles.
    Sharma S; Mukkur TK; Benson HA; Chen Y
    J Pharm Sci; 2012 Jan; 101(1):233-44. PubMed ID: 21953499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An inhalable β₂-adrenoceptor ligand-directed guanidinylated chitosan carrier for targeted delivery of siRNA to lung.
    Luo Y; Zhai X; Ma C; Sun P; Fu Z; Liu W; Xu J
    J Control Release; 2012 Aug; 162(1):28-36. PubMed ID: 22698944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration.
    Lv PP; Wei W; Yue H; Yang TY; Wang LY; Ma GH
    Biomacromolecules; 2011 Dec; 12(12):4230-9. PubMed ID: 22044456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biodegradable chitosan scaffolds containing microspheres as carriers for controlled transforming growth factor-beta1 delivery for cartilage tissue engineering.
    Cai DZ; Zeng C; Quan DP; Bu LS; Wang K; Lu HD; Li XF
    Chin Med J (Engl); 2007 Feb; 120(3):197-203. PubMed ID: 17355821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins.
    Grenha A; Remuñán-López C; Carvalho EL; Seijo B
    Eur J Pharm Biopharm; 2008 May; 69(1):83-93. PubMed ID: 18166446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Facile preparation of well-defined near-monodisperse chitosan/sodium alginate polyelectrolyte complex nanoparticles (CS/SAL NPs) via ionotropic gelification: a suitable technique for drug delivery systems.
    Liu P; Zhao X
    Biotechnol J; 2013 Jul; 8(7):847-54. PubMed ID: 23625874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a mucoadhesive nanoparticulate drug delivery system for a targeted drug release in the bladder.
    Barthelmes J; Perera G; Hombach J; Dünnhaupt S; Bernkop-Schnürch A
    Int J Pharm; 2011 Sep; 416(1):339-45. PubMed ID: 21726619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.